Long-term experiences with genetic consultation in people with hereditary breast and ovarian cancer
暂无分享,去创建一个
M. Golatta | C. Sohn | T. Bruckner | S. Schott | M. Keller | C. Domschke | J. Heil | L. Vetter | S. Eismann | N. Dikow | André Hennings
[1] A. Green,et al. Predictive Genetic Testing and Alternatives to Face to Face Results Disclosure: A Retrospective Review of Patients Preference for Alternative Modes of BRCA 1 and 2 Results Disclosure in the Republic of Ireland , 2016, Journal of Genetic Counseling.
[2] S. van Dulmen,et al. Counselees’ Expressed Level of Understanding of the Risk Estimate and Surveillance Recommendation are Not Associated with Breast Cancer Surveillance Adherence , 2016, Journal of Genetic Counseling.
[3] M. Golatta,et al. Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany , 2016, Breast Cancer Research and Treatment.
[4] P. Butow,et al. Public preferences for communicating personal genomic risk information: a focus group study , 2015, Health expectations : an international journal of public participation in health care and health policy.
[5] E. Hahnen,et al. Klassifizierung von „variants of unknown significance“ (VUS) beim familiären Brust- und Eierstockkrebs , 2015, medizinische genetik.
[6] R. Jagsi,et al. Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Martha B. Adams,et al. Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance , 2015, Journal of Genetic Counseling.
[8] L. Peipins,et al. Cognitive and affective influences on perceived risk of ovarian cancer , 2015, Psycho-oncology.
[9] M. Kartal,et al. Breast cancer risk perceptions of Turkish women attending primary care: a cross-sectional study , 2014, BMC Women's Health.
[10] S. Buys,et al. Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial. , 2014, Journal of the National Cancer Institute.
[11] QuinnJessica,et al. Perceived Versus Objective Breast Cancer Risk in Diverse Women , 2014 .
[12] K. Kerlikowske,et al. Perceived versus objective breast cancer risk in diverse women. , 2014, Journal of women's health.
[13] J. Garber,et al. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Suk-Jeong Lee,et al. Estimated risks and optimistic self-perception of breast cancer risk in Korean women. , 2013, Applied nursing research : ANR.
[15] H. Brunner,et al. More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling , 2013, Familial Cancer.
[16] Haley R. Eidem,et al. Effects of informed consent for individual genome sequencing on relevant knowledge , 2012, Clinical genetics.
[17] C. McBride,et al. Patients’ understanding of and responses to multiplex genetic susceptibility test results , 2012, Genetics in Medicine.
[18] Nina Ditsch,et al. Hereditary breast and ovarian cancer: new genes, new treatments, new concepts. , 2011, Deutsches Arzteblatt international.
[19] D. Evans,et al. Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany , 2011, Journal of Community Genetics.
[20] Perry W. Payne,et al. Regional differences in awareness and attitudes regarding genetic testing for disease risk and ancestry , 2010, Human Genetics.
[21] C. McBride,et al. Patient responses to genetic information: studies of patients with hereditary cancer syndromes identify issues for use of genetic testing in nephrology practice. , 2010, Seminars in nephrology.
[22] A. Samanek,et al. Australian Study on Public Knowledge of Human Genetics and Health , 2008, Public Health Genomics.
[23] Giovanni Parmigiani,et al. Meta-analysis of BRCA1 and BRCA2 penetrance. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] Lidewij Henneman,et al. Public Experiences, Knowledge and Expectations about Medical Genetics and the Use of Genetic Information , 2004, Public Health Genomics.
[25] S. Kardia,et al. Exploring the Public Understanding of Basic Genetic Concepts , 2004, Journal of Genetic Counseling.
[26] N. Facione,et al. Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. , 2004, Preventive medicine.
[27] P. Butow,et al. Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review , 2003, The Medical journal of Australia.
[28] W. Foulkes,et al. An evaluation of needs of female BRCA1and BRCA2 carriers undergoing genetic counselling , 2000, Journal of medical genetics.
[29] A. Clarke,et al. Why do women attend familial breast cancer clinics? , 2000, Journal of medical genetics.
[30] G. Lenoir,et al. An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer. , 1999, Cancer genetics and cytogenetics.
[31] A. Howell,et al. The impact of genetic counselling on risk perception in women with a family history of breast cancer. , 1994, British Journal of Cancer.
[32] S. Seal,et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.
[33] M. King,et al. Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.
[34] J. Klijn,et al. Psychological impact of receiving a BRCA1/BRCA2 test result. , 2001, American journal of medical genetics.
[35] B. Rimer,et al. Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want? , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.